{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:29:45Z","timestamp":1756312185180,"version":"3.41.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endometrial cancer (EC) has been one of the most general cancers with respect to gynecological malignancies; however, there are debates on clinical strategies concerning treatments especially for patients with grade 3 (G3) endometroid endometrial cancer (EEC). Present study aimed to evaluate the lymphatic metastasis (LM) related factors and figure out the necessity of lymphadenectomy for G3 EEC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From January 2009 to April 2019, 3751 EC patients were admitted to Obstetrics and Gynecology Hospital of Fudan University. Clinical characteristics include age, grade, stage, and clinical pathological features. A total of 1235 EEC patients were involved in the multivariable analysis. Three hundred and eighty-one patients were involved in the survival analysis and the data attributed to sufficient follow-up information. Kaplan-Meier curve and log-rank test were utilized to analyze the survival rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 1235 EEC patients, 181 (14.7%) were categorized as G3 and 1054 (85.3%) were grade 1 to grade 2 (G1-2). Multivariate analysis demonstrated that lymphovascular space invasion, adnexal involvement, and cervical stroma involvement were independent risk factors of LM in G3 cohort with odds ratio 3.4, 5.8, and 8.9; 95% confidence interval 1.1\u201310.6, 1.5\u201322.4, and 2.8\u201328.0, respectively. LM rates increased from 3.3% (3\/92) to 75% (9\/12) for G3 EEC cohort as related factor numbers increased from one to three. There were no differences between G3 and G1-2 EEC in overall survival and progression free survival. Additionally, no survival advantage was observed for G3 EEC patients at early stage with different plans of adjuvant treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>For G3 EEC patients without other pathological positive factor, the LM rate is lower than those with other pathological positive factor. Survival analysis showed no difference between G3 cohort and G1-2 cohort. Also, different adjuvant treatments had no impact on the overall survival for G3 EEC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001749","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T16:02:58Z","timestamp":1629993778000},"page":"2102-2109","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features related to lymphatic metastasis in grade 3 endometroid endometrial cancer: a retrospective cross-sectional study"],"prefix":"10.1097","volume":"134","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiong-Bo","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Zhen","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China"},{"name":"Department of Gynecology, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2217\/fon.14.192","article-title":"USA endometrial cancer projections to 2030: should we be concerned?","volume":"10","author":"Sheikh","year":"2014","journal-title":"Future Oncol"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","article-title":"FIGO staging for carcinoma of the vulva, cervix, and corpus uteri","volume":"125","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"(Suppl 1)","key":"R5-20250603","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R9-20250603","first-page":"1764","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.21037\/tcr.2019.04.23","article-title":"Sentinel node mapping in endometrial cancer","volume":"8","author":"Bogani","year":"2019","journal-title":"Transl Cancer Res"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1245\/s10434-017-5816-4","article-title":"Survival of patients with serous uterine carcinoma undergoing sentinel lymph node mapping","volume":"24","author":"Schiavone","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.chest.2020.03.010","article-title":"Sample size estimation in clinical research: from randomized controlled trials to observational studies","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jrsm.50","article-title":"Review of Fleiss, statistical methods for rates and proportions","volume":"2","author":"Senn","year":"2011","journal-title":"Res Synth Methods"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3802\/jgo.2012.23.4.251","article-title":"How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study","volume":"23","author":"Kang","year":"2012","journal-title":"J Gynecol Oncol"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000856","article-title":"Clinicopathologic association and prognostic value of microcystic, elongated, and fragmented (MELF) pattern in endometrial endometrioid carcinoma","volume":"41","author":"Kihara","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer \u2013 a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.sult.2019.04.001","article-title":"Imaging and staging of endometrial cancer","volume":"40","author":"Faria","year":"2019","journal-title":"Semin Ultrasound CT MR"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1245\/s10434-020-08261-8","article-title":"Adnexal involvement in endometrial cancer: prognostic factors and implications for ovarian preservation","volume":"27","author":"Baiocchi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/AOG.0b013e3181f98202","article-title":"Predicting parametrial involvement in endometrial cancer: is this the end for radical hysterectomies in stage II endometrial cancers?","volume":"116","author":"Disaia","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/PAS.0b013e3181f32168","article-title":"Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role","volume":"34","author":"Espinosa","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.24651","article-title":"Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis","volume":"116","author":"Baiocchi","year":"2017","journal-title":"J Surg Oncol"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/IGC.0000000000001229","article-title":"Prognostic significance of lymphovascular space invasion in the absence of lymph node metastases in early-stage endometrial cancer","volume":"28","author":"Cusano","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00404-020-05587-2","article-title":"Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis","volume":"302","author":"Petousis","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/jog.14422","article-title":"Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification","volume":"46","author":"Zhang","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2463\/mrms.mp.2016-0128","article-title":"Evaluating myometrial invasion in endometrial cancer: comparison of reduced field-of-view diffusion-weighted imaging and dynamic contrast-enhanced MR imaging","volume":"17","author":"Takeuchi","year":"2018","journal-title":"Magn Reson Med Sci"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/his.13871","article-title":"Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer","volume":"75","author":"Peters","year":"2019","journal-title":"Histopathology"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer \u2013 a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"58","author":"St\u00e5lberg","year":"2019","journal-title":"Acta Oncol"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/COC.0000000000000559","article-title":"Lymphovascular invasion in endometrial cancer: prognostic value and implications on adjuvant radiation therapy use","volume":"42","author":"Boothe","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.suronc.2020.03.004","article-title":"Is the extent of pelvic lymphadenectomy in the staging of endometrial cancer associated with the yield of metastatic nodes? An Israeli Gynecologic Oncology Group study","volume":"34","author":"Rottenstreich","year":"2020","journal-title":"Surg Oncol"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1023\/B:EJEP.0000036568.02655.f8","article-title":"Loss to follow-up in cohort studies: how much is too much?","volume":"19","author":"Kristman","year":"2004","journal-title":"Eur J Epidemiol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:17:13Z","timestamp":1748981833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":32,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001749","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"type":"print","value":"0366-6999"},{"type":"electronic","value":"2542-5641"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}